RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Subarachnoid Hemorrhage
Accession: DOID:9000438
browse the term
Definition: Bleeding into the intracranial or spinal SUBARACHNOID SPACE, most resulting from INTRACRANIAL ANEURYSM rupture. It can occur after traumatic injuries (SUBARACHNOID HEMORRHAGE, TRAUMATIC). Clinical features include HEADACHE; NAUSEA; VOMITING, nuchal rigidity, variable neurological deficits and reduced mental status.
Synonyms: exact_synonym: Aneurysmal Subarachnoid Hemorrhage; Aneurysmal Subarachnoid Hemorrhages; Intracranial Subarachnoid Hemorrhage; Intracranial Subarachnoid Hemorrhages; Perinatal Subarachnoid Hemorrhage; Perinatal Subarachnoid Hemorrhages; SAH (Subarachnoid Hemorrhage); SAHs (Subarachnoid Hemorrhage); Spontaneous Subarachnoid Hemorrhage; Spontaneous Subarachnoid Hemorrhages; Subarachnoid Hemorrhages
primary_id: MESH:D013345
xref: EFO:0000713 ; NCI:C50757
G
Abcc8
ATP binding cassette subfamily C member 8
treatment
IMP
RGD
PMID:24114458
RGD:10003028
NCBI chr 1:96,598,568...96,679,563
Ensembl chr 1:96,598,647...96,679,510
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:cerebrospinal fluid
RGD
PMID:22230897
RGD:8695949
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Adora1
adenosine A1 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18950269
NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
G
Ager
advanced glycosylation end product-specific receptor
IEP
mRNA, protein:increased expression:brain
RGD
PMID:24291745
RGD:8696000
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
Aif1
allograft inflammatory factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27157545
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
G
Apoe
apolipoprotein E
ISO
GAD
PMID:15118671
RGD:1331525
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
G
Aqp4
aquaporin 4
exacerbates
IEP IMP
mRNA:increased expression:brain:
RGD
PMID:33574749 PMID:33574749
RGD:127284879 , RGD:127284879
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
G
Aqp4em1Hrt
aquaporin 4; TALEN induced mutant 1, Hrt
exacerbates
IMP
RGD
PMID:33574749
RGD:127284879
G
Bcl2
BCL2, apoptosis regulator
treatment
IEP
RGD
PMID:26163325
RGD:13782347
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Becn1
beclin 1
IEP
protein:increased expression:brain
RGD
PMID:22521819
RGD:6483046
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
Bnip3
BCL2 interacting protein 3
treatment
IEP
RGD
PMID:23850688
RGD:11561986
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
G
C3
complement C3
treatment
IEP
RGD
PMID:26518242
RGD:11040780
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Casp3
caspase 3
treatment
ISO IDA
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:24602480 PMID:26163325
RGD:13782347
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
treatment
IDA
RGD
PMID:26163325
RGD:13782347
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Ccl20
C-C motif chemokine ligand 20
IEP
mRNA:increased expression:cerebral artery
RGD
PMID:17977275
RGD:7488893
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Cxcl1
C-X-C motif chemokine ligand 1
IEP
mRNA:increased expression:lung
RGD
PMID:20731855
RGD:4145368
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cybb
cytochrome b-245 beta chain
IEP
Protein:increased expression:cerebral cortex mRNA:increased expression:cerebral vessel:
RGD
PMID:16671452 PMID:12142572
RGD:1599680 , RGD:11040582
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
ISO
DNA:snp:cds:p.I118V (human)
RGD
PMID:18566305
RGD:5685415
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Ddit3
DNA-damage inducible transcript 3
treatment
IEP
RGD
PMID:30226536
RGD:35316073
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Edn1
endothelin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8587695
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Ednrb
endothelin receptor type B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8587695
NCBI chr15:80,640,839...80,672,115
Ensembl chr15:80,643,043...80,672,115
G
Epo
erythropoietin
treatment
ISO
RGD
PMID:23907045
RGD:10400909
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
G
Erbb4
erb-b2 receptor tyrosine kinase 4
treatment
ISO
RGD
PMID:28756200
RGD:151893490
NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595
G
Ern1
endoplasmic reticulum to nucleus signaling 1
treatment
IMP IEP
RGD
PMID:29169414 PMID:30226536
RGD:34901873 , RGD:35316073
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
G
Esr1
estrogen receptor 1
IEP
protein:increased expression:dentate gyrus
RGD
PMID:23465388
RGD:8553242
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Gli1
GLI family zinc finger 1
IEP
mRNA, protein:increased expression:brain
RGD
PMID:23933201
RGD:12859044
NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
G
Gpx3
glutathione peroxidase 3
ISO
protein:increased expression:plasma
RGD
PMID:32326289
RGD:401827845
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
G
Gsk3b
glycogen synthase kinase 3 beta
treatment
IDA
RGD
PMID:27026509
RGD:13792767
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
G
Gsn
gelsolin
disease_progression severity
IEP ISO
mRNA, protein:altered expression:cerebral cortex (rat) protein:decreased expression:blood plasma (human)
RGD
PMID:25744577 PMID:23880145
RGD:11055426 , RGD:329333027
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
G
Hcn1
hyperpolarization-activated cyclic nucleotide-gated potassium channel 1
IEP
mRNA,protein:decreased expression:hippocampus:
RGD
PMID:22378889
RGD:9686397
NCBI chr 2:49,495,771...49,899,983
Ensembl chr 2:49,495,771...49,899,774
G
Hif1a
hypoxia inducible factor 1 subunit alpha
IEP
protein:increased expression:brain
RGD
PMID:15703702
RGD:1626323
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hmox1
heme oxygenase 1
IMP IEP ISO
mRNA:increased expression:subarachnoid space
RGD
PMID:16543643 PMID:19686725 PMID:14657544
RGD:1582702 , RGD:4145300 , RGD:1598406
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hspd1
heat shock protein family D (Hsp60) member 1
IEP
mRNA:increased expression:brain stem
RGD
PMID:14753490
RGD:1624246
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
G
Htr1b
5-hydroxytryptamine receptor 1B
IEP
RGD
PMID:17542534
RGD:1626451
NCBI chr 8:82,513,572...82,534,670
Ensembl chr 8:82,517,360...82,534,549
G
Icam1
intercellular adhesion molecule 1
IEP
mRNA:increased expression:lung (rat)
RGD
PMID:20731855
RGD:4145368
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Il1b
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27157545
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
ISO
rat model treated with human protein
RGD
PMID:22679224
RGD:7051590
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27157545
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Irf9
interferon regulatory factor 9
ameliorates
IMP
RGD
PMID:29480757
RGD:125093745
NCBI chr15:29,095,474...29,101,924
Ensembl chr15:29,095,789...29,101,236
G
Kcnj10
potassium inwardly-rectifying channel, subfamily J, member 10
treatment
IEP
RGD
PMID:22420318
RGD:8662908
NCBI chr13:84,802,026...84,835,383
Ensembl chr13:84,802,009...84,835,461
G
Lcn2
lipocalin 2
ameliorates
ISO
RGD
PMID:26463936
RGD:126781835
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
treatment
IEP
RGD
PMID:30226536
RGD:35316073
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
G
Map3k7
mitogen activated protein kinase kinase kinase 7
treatment
IEP
RGD
PMID:29273596
RGD:155804269
NCBI chr 5:46,356,973...46,415,597
Ensembl chr 5:46,357,931...46,415,597
G
Mmp1
matrix metallopeptidase 1
no_association
ISO
RGD
PMID:11546917
RGD:1582365
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
G
Mmp13
matrix metallopeptidase 13
IDA
RGD
PMID:16961140
RGD:1582545
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
G
Mmp2
matrix metallopeptidase 2
IDA
RGD
PMID:22475348
RGD:8657107
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:27157545 PMID:17410600
RGD:1642039
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Nfe2l2
NFE2 like bZIP transcription factor 2
treatment
IEP
RGD
PMID:22304528
RGD:10412722
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Ngb
neuroglobin
IEP
protein:increased expression:cerebral cortex
RGD
PMID:24281943
RGD:9743950
NCBI chr 6:106,744,378...106,749,830
Ensembl chr 6:106,744,378...106,749,830
G
Nlk
nemo like kinase
disease_progression
IEP
RGD
PMID:23325309
RGD:12791279
NCBI chr10:63,467,388...63,590,960
Ensembl chr10:63,438,222...63,589,730
G
Nos2
nitric oxide synthase 2
ISO
mRNA:increased expression:brainstem, basilar artery (mouse) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17053178 PMID:21915076
RGD:5509046
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nos3
nitric oxide synthase 3
IEP
mRNA:increased expression:parietal cortex, arteriole (rat)
RGD
PMID:11273938
RGD:7794687
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Nqo1
NAD(P)H quinone dehydrogenase 1
IEP
mRNA, protein:increased expression:brain
RGD
PMID:21259333
RGD:5133235
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nrg1
neuregulin 1
treatment
ISO
RGD
PMID:28756200
RGD:151893490
NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884
G
Ntn1
netrin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29162556
NCBI chr10:52,899,933...53,098,591
Ensembl chr10:52,899,934...53,085,326
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
IDA
RGD
PMID:21193742
RGD:5684779
NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136
G
Pdcd10
programmed cell death 10
IEP
protein:decreased expression:brain, microglial cell (rat)
RGD
PMID:32302649
RGD:401827168
NCBI chr 2:160,303,465...160,346,086
Ensembl chr 2:160,303,449...160,346,018
G
Pdgfrb
platelet derived growth factor receptor beta
ameliorates
IMP
RGD
PMID:29480757
RGD:125093745
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
G
Pik3cb
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
treatment
ISO
RGD
PMID:28756200
RGD:151893490
NCBI chr 8:99,594,600...99,699,772
Ensembl chr 8:99,594,644...99,699,663
G
Pkd1l1
polycystin 1 like 1, transient receptor potential channel interacting
susceptibility
ISO
DNA:polymorphism:cds:p.Gly243Asp(human)
RGD
PMID:16741147
RGD:155630602
NCBI chr14:83,552,964...83,670,062
Ensembl chr14:83,545,469...83,638,498
G
Pparg
peroxisome proliferator-activated receptor gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29162556
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Prkn
parkin RBR E3 ubiquitin protein ligase
treatment
IEP
RGD
PMID:28546552
RGD:13432565
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
G
Ptch1
patched 1
IEP
mRNA, protein:increased expression:brain
RGD
PMID:23933201
RGD:12859044
NCBI chr17:1,542,705...1,607,730
Ensembl chr17:1,542,877...1,607,333
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
RGD
PMID:21725746
RGD:5508204
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Rela
RELA proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27157545
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Shh
sonic hedgehog signaling molecule
IEP
mRNA, protein:increased expression:brain
RGD
PMID:23933201
RGD:12859044
NCBI chr 4:6,954,017...6,963,170
Ensembl chr 4:6,954,017...6,963,170
G
Smo
smoothened, frizzled class receptor
treatment
IDA
RGD
PMID:28149272
RGD:150521623
NCBI chr 4:58,343,626...58,373,823
Ensembl chr 4:58,343,529...58,373,829
G
Stat3
signal transducer and activator of transcription 3
IEP
mRNA, protein:increased expression, increased phosphorylation:cerebral artery
RGD
PMID:24517975
RGD:8694356
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Tacr1
tachykinin receptor 1
IMP
RGD
PMID:17542534
RGD:1626451
NCBI chr 4:114,920,844...115,089,733
Ensembl chr 4:114,920,844...115,089,733
G
Tjp1
tight junction protein 1
IDA
protein:altered localization
RGD
PMID:18854840
RGD:2325137
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
G
Tlr4
toll-like receptor 4
IEP
mRNA, protein:increased expression:brain
RGD
PMID:19719951
RGD:4144093
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tmbim6
transmembrane BAX inhibitor motif containing 6
treatment
IDA IEP
mRNA,protein:decreased expression:brain
RGD
PMID:30226536 PMID:30226536
RGD:35316073 , RGD:35316073
NCBI chr 7:130,527,313...130,542,567
Ensembl chr 7:130,527,316...130,543,633
G
Tnc
tenascin C
IEP
protein:increased expression:basilar artery
RGD
PMID:19589197
RGD:4889600
NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624
G
Tnf
tumor necrosis factor
IEP ISO
protein:increased expression:brain CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:27157545 PMID:19719951
RGD:4144093
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Trem1
triggering receptor expressed on myeloid cells 1
treatment severity
IEP ISO
RGD
PMID:30910643 PMID:33727099
RGD:127284863 , RGD:127284864
NCBI chr 9:12,763,819...12,779,285
Ensembl chr 9:12,763,819...12,779,203
G
Trpm4
transient receptor potential cation channel, subfamily M, member 4
IEP
protein:increased expression:entorhinal cortex
RGD
PMID:24114458
RGD:10003028
NCBI chr 1:95,781,805...95,812,095
Ensembl chr 1:95,782,000...95,812,532
G
Unc5b
unc-5 netrin receptor B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29162556
NCBI chr20:28,697,726...28,764,474
Ensembl chr20:28,697,726...28,764,537
G
Yap1
Yes1 associated transcriptional regulator
treatment
ISO
RGD
PMID:28756200
RGD:151893490
NCBI chr 8:5,095,705...5,166,808
Ensembl chr 8:5,095,722...5,167,010
G
Abcc8
ATP binding cassette subfamily C member 8
treatment
IMP
RGD
PMID:18854840
RGD:2325137
NCBI chr 1:96,598,568...96,679,563
Ensembl chr 1:96,598,647...96,679,510
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all